Status of vaccine research and development of vaccines for Nipah virus

Benjamin A. Satterfield, Brian E. Dawes, Gregg Milligan

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Nipah virus (NiV) is a highly pathogenic, recently emerged paramyxovirus that has been responsible for sporadic outbreaks of respiratory and encephalitic disease in Southeast Asia. High case fatality rates have also been associated with recent outbreaks in Malaysia and Bangladesh. Although over two billion people currently live in regions in which NiV is endemic or in which the Pteropus fruit bat reservoir is commonly found, there is no approved vaccine to protect against NiV disease. This report examines the feasibility and current efforts to develop a NiV vaccine including potential hurdles for technical and regulatory assessment of candidate vaccines and the likelihood for financing.

Original languageEnglish (US)
Pages (from-to)2971-2975
Number of pages5
JournalVaccine
Volume34
Issue number26
DOIs
StatePublished - Jun 3 2016

Fingerprint

Nipah Virus
Nipah virus
research and development
Vaccines
vaccines
Research
Disease Outbreaks
Pteropus
Respirovirus
Southeastern Asia
Bangladesh
Malaysia
Virus Diseases
South East Asia
funding
Chiroptera
Fruit
fruits
Mortality

Keywords

  • Live attenuated vaccine
  • Nipah virus
  • Soluble G protein
  • Subunit vaccine

ASJC Scopus subject areas

  • Immunology and Microbiology(all)
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)
  • Molecular Medicine

Cite this

Status of vaccine research and development of vaccines for Nipah virus. / Satterfield, Benjamin A.; Dawes, Brian E.; Milligan, Gregg.

In: Vaccine, Vol. 34, No. 26, 03.06.2016, p. 2971-2975.

Research output: Contribution to journalArticle

Satterfield, Benjamin A. ; Dawes, Brian E. ; Milligan, Gregg. / Status of vaccine research and development of vaccines for Nipah virus. In: Vaccine. 2016 ; Vol. 34, No. 26. pp. 2971-2975.
@article{692c25e2878b46c2a26d1c85396b582c,
title = "Status of vaccine research and development of vaccines for Nipah virus",
abstract = "Nipah virus (NiV) is a highly pathogenic, recently emerged paramyxovirus that has been responsible for sporadic outbreaks of respiratory and encephalitic disease in Southeast Asia. High case fatality rates have also been associated with recent outbreaks in Malaysia and Bangladesh. Although over two billion people currently live in regions in which NiV is endemic or in which the Pteropus fruit bat reservoir is commonly found, there is no approved vaccine to protect against NiV disease. This report examines the feasibility and current efforts to develop a NiV vaccine including potential hurdles for technical and regulatory assessment of candidate vaccines and the likelihood for financing.",
keywords = "Live attenuated vaccine, Nipah virus, Soluble G protein, Subunit vaccine",
author = "Satterfield, {Benjamin A.} and Dawes, {Brian E.} and Gregg Milligan",
year = "2016",
month = "6",
day = "3",
doi = "10.1016/j.vaccine.2015.12.075",
language = "English (US)",
volume = "34",
pages = "2971--2975",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "26",

}

TY - JOUR

T1 - Status of vaccine research and development of vaccines for Nipah virus

AU - Satterfield, Benjamin A.

AU - Dawes, Brian E.

AU - Milligan, Gregg

PY - 2016/6/3

Y1 - 2016/6/3

N2 - Nipah virus (NiV) is a highly pathogenic, recently emerged paramyxovirus that has been responsible for sporadic outbreaks of respiratory and encephalitic disease in Southeast Asia. High case fatality rates have also been associated with recent outbreaks in Malaysia and Bangladesh. Although over two billion people currently live in regions in which NiV is endemic or in which the Pteropus fruit bat reservoir is commonly found, there is no approved vaccine to protect against NiV disease. This report examines the feasibility and current efforts to develop a NiV vaccine including potential hurdles for technical and regulatory assessment of candidate vaccines and the likelihood for financing.

AB - Nipah virus (NiV) is a highly pathogenic, recently emerged paramyxovirus that has been responsible for sporadic outbreaks of respiratory and encephalitic disease in Southeast Asia. High case fatality rates have also been associated with recent outbreaks in Malaysia and Bangladesh. Although over two billion people currently live in regions in which NiV is endemic or in which the Pteropus fruit bat reservoir is commonly found, there is no approved vaccine to protect against NiV disease. This report examines the feasibility and current efforts to develop a NiV vaccine including potential hurdles for technical and regulatory assessment of candidate vaccines and the likelihood for financing.

KW - Live attenuated vaccine

KW - Nipah virus

KW - Soluble G protein

KW - Subunit vaccine

UR - http://www.scopus.com/inward/record.url?scp=84961184231&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961184231&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2015.12.075

DO - 10.1016/j.vaccine.2015.12.075

M3 - Article

C2 - 26973068

AN - SCOPUS:84961184231

VL - 34

SP - 2971

EP - 2975

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 26

ER -